Stryker sees FY25 adjusted EPS $13.20-$13.45, consensus $13.45

The company said, “Considering our first quarter results, strong demand for our capital products and our commercial momentum in the end markets in which we operate, we are raising our full year 2025 organic net sales growth(2) guidance range to 8.5% to 9.5%. Our updated sales guidance reflects a modestly favorable pricing impact and a slightly unfavorable foreign exchange impact should foreign exchange rates hold near current levels.”